NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/28/2026
Back to search
Official data from USPTO
SERIOUS MEDICINE. EXTRAORDINARY CARE.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SERIOUS MEDICINE. EXTRAORDINARY CARE.
ST13
US500000078259022Class
35, 42, 44
Filing
78259022
Registration
2973388
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/24/2026
Trademark type
Word
Nice classes
35, 42, 44
Filing date
06/05/2003
Registration date
07/19/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/28/2026
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/02/2005
First use in commerce
03/02/2005
Drawing code
1
Owner type
03
Owner location
OMAHA, NE, US
Examiner
CHHINA, KARANENDRA S
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NEBRASKA MEDICAL CENTER, THE
N. S. (pessoa física)
Representatives
Alison W. Jarzyna Larkin Hoffman Daly & Lindgren Ltd.
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Medical referrals
Class 42
Medical laboratories and medical research
Class 44
Hospitalheath * health * care and medical servicesemergency medical assistancemedical clinicsmedical counselingproviding medical informationmedical testing
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02/28/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/28/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/28/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
12/04/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/19/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
03/24/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/24/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/24/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/24/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
03/08/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/13/2011
E815
TEAS SECTION 8 & 15 RECEIVED
01/06/2011
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/09/2005
PLGL
ASSIGNED TO PARALEGAL
12/01/2005
C.7F
REQUEST FOR NEW CERTIFICATE FILED
09/19/2005
PAPER RECEIVED
09/19/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
07/19/2005
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/11/2005
ALIE
ASSIGNED TO LIE
05/06/2005
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/04/2005
PAPER RECEIVED
05/02/2005
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/19/2005
IUAF
USE AMENDMENT FILED
03/25/2005
PAPER RECEIVED
03/25/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/14/2004
PAPER RECEIVED
10/13/2004
PUBO
PUBLISHED FOR OPPOSITION
09/21/2004
PAPER RECEIVED
09/01/2004
NPUB
NOTICE OF PUBLICATION
09/01/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2004
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/22/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2004
PAPER RECEIVED
06/22/2004
GNRT
NON-FINAL ACTION E-MAILED
12/27/2003
DOCK
ASSIGNED TO EXAMINER
12/09/2003
Continuous trademark protection
Get notified about every new filing that threatens SERIOUS MEDICINE. EXTRAORDINARY CARE. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.